Award

Investigating mechanisms of accelerated arterial aging in post-menopausal females

Description: During the lifetime of all mammals, the cardiovascular system suffers many changes in function and structure that decrease its performance. One known hallmark of vascular deterioration is arterial stiffening, where large vessels become stiffer as we age, and is an independent predictor of major adverse cardiovascular events. The risk of cardiovascular disease (CVD) augments in both men and women with age, however there is a significant risk acceleration in women after menopause. To date, there are no known therapeutics that directly target aging induced vascular stiffening, and the mechanisms involved in sex differences in arterial aging are yet to be determined. We identified lysyl oxidase like 2 (LOXL2) as a novel target for arterial stiffening that participates in extracellular matrix remodeling, and we further showed that LOXL2 depletion is protective against arterial stiffening in aging in both male and female mice. We also found that LOXL2 expression is augmented in post-menopausal female aortas compared to age-matched males. The shift from estrogens dominance to a relative androgen excess in post-menopausal women is an important and as yet poorly understood element of cardiovascular aging. We hypothesize that an abrupt increase in LOXL2 expression and activity in the vasculature occurs as a result of this hormonal imbalance, resulting in accelerated arterial stiffening in post-menopausal women. We will test this hypothesis through two specific aims. In Aim 1, we will investigate the role of LOXL2 in female arterial aging using mouse model of menopause. In Aim 2, we will use in vitro cell culture approaches, to study the hormonal imbalance of androgen and estrogen present in post-menopausal females, and its relation to LOXL2 expression and activity and thence, vascular stiffening. We will determine if the effect of sex hormones on LOXL2 is direct, or indirect through endothelial dysfunction and decrease of nitric oxide bioavailability. These studies will fill the gaps in our understanding regarding the regulation of LOXL2 by sex hormones and its role in the acceleration of vascular stiffening in post-menopausal females.
Amount: $67,390
Funding type: training
Funder scheme: Predoctoral Fellowship
Start date: 2024-01-01
End date: 2025-12-31
Institutions: Johns Hopkins University, Johns Hopkins University School of Medicine
Field: Medicine
Funded outputs count: 0
Funder award ID: 24PRE1196370
OpenAlex ID: G7862647993